Abstract
AbstractThis editorial is to highlight current issues of heart failure management during COVID-19 pandemic.
Publisher
Springer Science and Business Media LLC
Reference18 articles.
1. Bleumink GS, Knetsch AM, Sturkenboom MC, Strauss SAM, Hofman A, Deckers JW, et al. Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure—The Rotterdam Study. Eur Heart J. 2004;25:1614–9.
2. Du RH, Liu LM, Yin W, Wang W, Guan LL, Yuan ML, et al. Hospitalization and critical care of 109 decedents with COVID-19 pneumonia in Wuhan, China. Ann Am Thorac Soc. 2020;17:839–46.
3. Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F, et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. 2020;5(7):802–10.
4. Kini A, Cao D, Nardin M, Sartori S, Zhang ZJ, Pivato CA, et al. Types of myocardial injury and mid-term outcomes in patients with COVID-19. Eur Heart J Qual Care Clin Outcomes. 2021;7(5):438–46.
5. Harrison SL, Buckley BJR, Rivera-Caravaca JM, Zhang JQ, Lip GYH. Cardiovascular risk factors, cardiovascular disease, and COVID-19: an umbrella review of systematic reviews. Eur Heart J Qual Care Clin Outcomes. 2021;7(4):330–9.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献